Business · 18/03/2015Updated: 10/17/2026 · 1 min read
FDA Amends Notice of Cardiovascular and Renal Drugs Advisory Committee Meeting
Summary
The US Food and Drug Administration (FDA) is updating the meeting details of the Cardiovascular and Renal Drugs Advisory Committee, originally announced on February 27, 2015, with no additional changes.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →